Home › NDC Lookup › Ingredients › Sennosides › 54859-0808-08
🧴image loading
(from DailyMed)

Senna Syrup Sennosides 8.8 mg/5mL Liquid, 237 mL

by Llorens Pharmaceutical International Division, Inc. · 237 mL in 1 BOTTLE (54859-808-08)
NDC 54859-0808-08
🏷️ FDA NDC (as labeled) 54859-808-08 billing pads the product segment with a zero
OTC On market Non-controlled
🗂️ Data synced Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

🆔 Identity & classification

FDA NDC (as labeled) 54859-808-08
Product NDC 54859-808
11-digit billing NDC 54859080808
NCPDP billing unit ML — per mL (volume)
RxCUI 702311
UNII 3FYP5M0IJX
UPC 0354859808080
Application # M007
SPL Set ID 5be0163c-b7f7-46db-b738-78c2946a6cf6
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2019-05-01
Route ORAL
Dosage form LIQUID
Substance SENNOSIDES
GPI-14 46200060201220
GPI class Senna
GCN Seq No 002922
GCN 08660
HICL code 001289
Ingredient (HICL) Sennosides
HIC1 code D
Therapeutic class — broad (HIC1) Biliary System/Gastro-Intestinal System
HIC2 code D6
Therapeutic class — intermediate (HIC2) Drugs Acting Principally On The Colon
HIC3 code D6S
Therapeutic class — specific (HIC3) Laxatives And Cathartics
AHFS code 56:12.00.00
AHFS class Cathartics And Laxatives
FDB label name SENNA 8.8 MG/5 ML SYRUP
FDB brand name Senna
Legend status O — Over-the-counter (OTC) drug or device
Why two NDCs? The FDA registers this code as 54859-808-08 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 54859-0808-08. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

🏷️ RxNorm drug class

This medicine belongs to the Contact laxatives class.

Drug family (ATC) Contact laxatives
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

🏭 Manufacturer & labeler

LabelerLlorens Pharmaceutical International Division, Inc.
FDA applicationM007 (OTC MONOGRAPH DRUG)
Labeler code54859
First marketedMay 2019
Product typeHuman Otc Drug
Portfolio12 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

🩺 Clinical

Label name SENNA 8.8 MG/5 ML SYRUP Ingredient Sennosides
📗 Our plain-language guide HelloPharmacist
  • Senna typically produces a bowel movement within 6 to 12 hours. That's why most people take it at bedtime — so it can do its job overnight and you get results in the morning. If no...
  • How long does it take for senna to work?
  • Senna is designed for short-term, occasional use. You should not use it for more than 1 week unless your doctor specifically tells you it's okay. Using laxatives too often or for t...
  • Laxatives like senna can affect how your body absorbs other medications. To be safe, take senna at least 2 hours before or after any other drugs you use. It's always a good idea to...
📖 Read our full Senna guide →
3
Nutrient depletion considerations

Sennosides (OTC drug) may be associated with lower levels of 3 nutrients — worth a chat with your pharmacist, not a cause for alarm.

🧪 Full Sennosides (OTC drug) nutrient depletion report →
An association is not a deficiency. Educational only — don't start or stop anything without professional guidance.
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

🧪 Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII A2I8C7HI9T
    Methylparaben is a preservative derived from benzoic acid that prevents growth of bacteria, fungi, and mold in medicines. It extends the product's shelf life and maintains safety during storage.
  • UNII 6DC9Q167V3
    Propylene glycol is a clear liquid derived from petroleum or vegetable sources. It acts as a solvent, humectant, and preservative in medicines, helping dissolve active ingredients and maintain product stability.
  • UNII Z8IX2SC1OH
    Propylparaben is a chemical preservative used to prevent bacterial and fungal growth in medicines and personal care products. It helps extend shelf life and maintain product safety during storage.
  • UNII 96K6UQ3ZD4
    Sucralose is a synthetic sweetener made from sugar. It's added to medicines to improve taste without adding calories, helping make bitter or unpleasant-tasting drugs easier to take.
  • UNII 059QF0KO0R
    Water is a liquid solvent that dissolves and mixes ingredients together in liquid medicines, syrups, and injections. It helps distribute the active drug evenly throughout the product.

5 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statesInactive ingredients artificial and natural chocolate flavor, citric acid, glycerin, methylparaben, potassium sorbate, propylparaben, purified water, and sucrose.

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

💲 Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer mLPer package
Retail pharmacies payNADAC · weekly $0.038 $8.89 / 237 ml
Medicaid paysCMS SDUD · 12 mo $0.0667 $15.81 / 237 ml
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
NADAC price history (per mL) — tap or hover for the price & month
Oct 2022 Feb 2024 Mar 2026 Aug 2026 $0.044 $0.035
▼ Down 14% over the last 14 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

🔁 Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Senna Liquid 8.8 mg/5mL 00536-1266-59 RUGBY 237 ml $0.038 — Availability likely —
Senna 8.8 mg/5mL 39328-0020-08 Patrin 237 ml $0.038 — Availability likely —
Senna Syrup 8.8 mg/5mLthis 54859-0808-08 Llorens 237 ml $0.038 — Availability likely —
Senna Syrup 8.8 mg/5mL 57237-0301-24 Rising 237 ml $0.038 — Availability likely —
Senna Syrup 8.8 mg/5mL 58657-0518-08 Method 237 ml $0.038 — Availability likely —
Senna 8.8 mg/5mL 82568-0024-08 AARNA 237 ml $0.038 — Availability likely —
Senna 8.8 mg/5mL 00121-4967-40 PAI 10 cups — — FDA listed —
Senna 8.8 mg/5mL 00536-1483-59 Rugby 237 ml — — FDA listed —
Senna 8.8 mg/5mL 00904-7528-94 Major 10 cups — — FDA listed —
OneLAX SENNA 417.12 mg/237mL 17856-1127-01 ATLANTIC 120 syringes — — FDA listed —
OneLAX SENNA 417.12 mg/237mL 17856-8127-02 Atlantic 50 cups — — FDA listed —
Senna UD 8.8 mg/5mL 39328-0120-50 Patrin 10 cups — — FDA listed —
Senna UD 26.4 mg/15mL 39328-0220-50 Patrin 10 cups — — FDA listed —
Senna Syrup 8.8 mg/5mL 48433-0219-40 Safecor 40 cups — — FDA listed —
Senna Syrup 8.8 mg/5mL 50268-0731-24 AVPAK 24 cups — — FDA listed —
Senna Syrup 8.8 mg/5mL 57237-0310-54 Rising 40 cups — — FDA listed —
GeriCare Senna Syrup 8.8 mg/5mL 57896-0472-08 Geri-Care 237 ml — — FDA listed —
Senna 8.8 mg/5mL 60687-0851-77 American 10 cups — — FDA listed —
Senna Syrup 8.8 mg/5mL 63629-9268-01 Bryant 237 ml — — FDA listed —
SENNA Syrup 8.8 mg/5mL 66424-0562-08 SDA 236 ml — — FDA listed —
Senna 417.12 mg/237mL 68094-0049-62 Precision 10 cups — — FDA listed —
Senna 8.8 mg/5mL 69618-0069-58 Reliable 237 ml — — FDA listed —
OneLAX SENNA 417.12 mg/237mL 71399-0027-08 Akron 237 ml — — FDA listed —
Senna Syrup 8.8 mg/5mL 72090-0022-01 Pioneer 237 ml — — FDA listed —
Senna Syrup 8.8 mg/5mL 72162-1672-02 Bryant 237 ml — — FDA listed —
Senna Syrup 8.8 mg/5mL 73564-0812-08 Aldama 1 bottle — — FDA listed —
Senna Syrup 8.8 mg/5mL 81033-0120-50 Kesin 50 cups — — FDA listed —
Senna Syrup 8.8 mg/5mL 84415-0021-01 Everpharm 100 cups — — FDA listed —
Senna Liquid 8.8 mg/5mL 84447-0120-01 Belleview 200000 ml — — FDA listed —
Curewell Senna Syrup 8.8 mg/5mL 85111-0452-08 RMT 1 bottle — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

⏳ Availability & generic status

🏛️
2019
On the market since
May 2019
📍
2026
Currently FDA-listed
7 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

🗺️ Medicaid utilization & spend

📍 This exact package only: Medicaid data is reported per full 11-digit NDC — labeler, product and pack size — so every number here is for 54859-0808-08, not the drug overall. Other pack sizes report separately.
💊 Pharmacy benefit only: These are Medicaid outpatient pharmacy claims, billed by NDC. They exclude the medical benefit — clinic- or hospital-administered drugs billed under HCPCS J-codes — so drugs used mostly that way (e.g. Avastin, Lucentis, Keytruda) can look low or missing here. That’s expected, not an error.
📅 Q1 2025 – Q4 2025 · 4 quarters of data
ⓘ The newest quarter is usually incomplete when first published; states restate recent quarters in later CMS releases, so the latest figures typically revise upward. State coverage-policy changes can also shift quarter-to-quarter totals.
Prescriptions last 4 qtrs
1.9K
Units reimbursed last 4 qtrs
415.3K
Gross reimbursed last 4 qtrs
$27.7K
Avg / prescription
$14.80
Avg / unit
$0.0667
Latest quarter Q4 2025
426Rx
Medicaid pays / mL
$0.0667
gross reimbursed
vs
NADAC / mL
$0.0375
acquisition cost
=
Spread
+$0.0292
+78% vs cost
What Medicaid paid per mL (before rebates; includes the pharmacy’s dispensing fee) compared with NADAC — the average price pharmacies pay to buy the drug. A positive spread means Medicaid reimbursed more than the purchase price, before manufacturer rebates.
Fee-for-service vs managed care ⓘ
66% FFS 34% MCO
Fee-for-service · 1,234 Rx Managed care · 637 Rx
State Medicaid map
Alaska: no data reported AK Maine: no data reported ME Washington: no data reported WA Idaho: no data reported ID Montana: no data reported MT North Dakota: no data reported ND Minnesota: 2,476 units · 43.2 per 100k residents MN Wisconsin: 34,683 units · 587 per 100k residents WI Michigan: 18,500 units · 184 per 100k residents MI New York: 119,290 units · 610 per 100k residents NY Vermont: 11,503 units · 1,778 per 100k residents VT New Hampshire: no data reported NH Oregon: no data reported OR Nevada: no data reported NV Wyoming: no data reported WY South Dakota: no data reported SD Iowa: no data reported IA Illinois: no data reported IL Indiana: no data reported IN Ohio: 93,105 units · 790 per 100k residents OH Pennsylvania: 11,911 units · 91.9 per 100k residents PA New Jersey: 16,961 units · 183 per 100k residents NJ Massachusetts: no data reported MA California: 24,017 units · 61.6 per 100k residents CA Utah: no data reported UT Colorado: no data reported CO Nebraska: no data reported NE Missouri: no data reported MO Kentucky: 12,401 units · 274 per 100k residents KY West Virginia: no data reported WV Virginia: no data reported VA Maryland: 14,640 units · 237 per 100k residents MD Connecticut: no data reported CT Rhode Island: no data reported RI Arizona: no data reported AZ New Mexico: no data reported NM Kansas: 2,395 units · 81.5 per 100k residents KS Arkansas: no data reported AR Tennessee: 34,215 units · 480 per 100k residents TN North Carolina: no data reported NC South Carolina: 19,175 units · 357 per 100k residents SC Delaware: no data reported DE Oklahoma: no data reported OK Louisiana: no data reported LA Mississippi: no data reported MS Alabama: no data reported AL Georgia: no data reported GA D.C.: no data reported DC Hawaii: no data reported HI Texas: no data reported TX Florida: no data reported FL
Units reimbursed · per 100k residents
43.21,778
gray = no data reported ⓘ
Colors are per 100,000 residents, so big states don’t automatically dominate. Tap or hover a state for its actual totals.
Tap or hover a state
…for its Medicaid breakdown
🏆 Top states by units · per 100k residents
1 Vermont 1,778 /100k
2 Ohio 790 /100k
3 New York 610 /100k
4 Wisconsin 587 /100k
5 Tennessee 480 /100k
6 South Carolina 357 /100k
7 Kentucky 274 /100k
8 Maryland 237 /100k
National units — by quarter
💵 About the dollar figures: “reimbursed” is what Medicaid paid pharmacies before confidential manufacturer rebates, so the program’s real net cost is lower than these numbers. Fee-for-service and managed-care claims are combined unless split above. Source: CMS State Drug Utilization Data; per-100k rates use 2023 Census population estimates.

🔬 Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Senna Syrup (this brand).

Top reported reactions

Pyrexia701
Pain651
Constipation646
Fatigue642
Dyspnoea613
Headache611
Asthma563

Age at onset

Infant4
Child24
Adolescent26
Adult611
Elderly1,020

Reporter sex

7,208 reports
Male · 48%
Female · 52%
Unknown · 0%

Serious outcomes

Hospitalization4,040
Life-threatening917
Disabling213
Reports over time (by year) — tap or hover for the count & year
2020 2022 2024 2026 926 0
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.

📦 Packaging — all sizes for this product

Package NDCDescription Marketing startStatus
54859-0808-08 You're viewing this 237 mL in 1 BOTTLE (54859-808-08) 2019-05-01 Active

📄 FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 🤰 Pregnancy 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose
🎯 Indications and Usage 14 words ▾

Uses relieves occasional constipation (irregularity) generally causes bowel movment in 6 to 12 hours

⏱️ Dosage and Administration 59 words ▾

shake well before use Do not exceed recommended dose Age Starting Dose Maximum dosage Adults and children 12 years and older 2-3 teaspoonfuls once a day preferably at bedtime; increase as needed or as recommended by a doctor 3 teaspoons in the morning and 3 teaspoons at bedtime Under 12 years of age ask a doctor ask a doctor

⚠️ Warnings 73 words ▾

Warnings Do not use laxative products for longer than 1 week unless directed by a doctor Ask a doctor or pharmacis before use if you have stomach pain nausea vomiting noticed a sudden changed in bowel movement that continues over a period of 2 weeks Stope use and ask a doctor if you have rectal bleeding or failure to have a bowel movemebt after use of laxative. They may indicate a serious condition.

🤰 Pregnancy 10 words ▾

If pregnant or breast-feeding ask a health professional before use

🧪 Active Ingredient 6 words ▾

Per teaspoonful-5mL Sennosides - 8.8 mg

🧪 Inactive Ingredients 18 words ▾

Inactive ingredients artificial and natural chocolate flavor, citric acid, glycerin, methylparaben, potassium sorbate, propylparaben, purified water, and sucrose.

🎯 Purpose 2 words ▾

Purpose Laxative

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗
← 54859-0803-16 · Llorens 54859-0809-16 · LLORENS →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.